State of Alaska Department of Revenue’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,030
| Closed | -$558K | – | 1589 |
|
|
2024
Q3 | $558K | Sell |
2,030
-2,245
| -53% | -$617K | 0.01% | 1373 |
|
|
2024
Q2 | $1.04M | Buy |
+4,275
| New | +$1.04M | 0.01% | 981 |
|
|
2021
Q2 | – | Sell |
-34,017
| Closed | -$4.8M | – | 1644 |
|
|
2021
Q1 | $4.8M | Sell |
34,017
-4,148
| -11% | -$586K | 0.05% | 383 |
|
|
2020
Q4 | $4.96M | Sell |
38,165
-4,097
| -10% | -$532K | 0.06% | 360 |
|
|
2020
Q3 | $6.15M | Buy |
42,262
+14,054
| +50% | +$2.05M | 0.08% | 294 |
|
|
2020
Q2 | $4.18M | Buy |
+28,208
| New | +$4.18M | 0.05% | 410 |
|
|
2019
Q3 | – | Sell |
-11,061
| Closed | -$802K | – | 1638 |
|
|
2019
Q2 | $802K | Buy |
11,061
+152
| +1% | +$11K | 0.01% | 852 |
|
|
2019
Q1 | $1.02M | Buy |
10,909
+86
| +0.8% | +$8.03K | 0.02% | 719 |
|
|
2018
Q4 | $789K | Buy |
10,823
+71
| +0.7% | +$5.18K | 0.02% | 748 |
|
|
2018
Q3 | $940K | Buy |
10,752
+292
| +3% | +$25.5K | 0.02% | 754 |
|
|
2018
Q2 | $1.03M | Buy |
10,460
+2,590
| +33% | +$255K | 0.02% | 695 |
|
|
2018
Q1 | $936K | Buy |
7,870
+1,570
| +25% | +$187K | 0.02% | 699 |
|
|
2017
Q4 | $800K | Buy |
+6,300
| New | +$800K | 0.02% | 671 |
|